Main > ONCOLOGY (**) > Kidney Cancer>RCC>MET *** > Treatment > USA. P. TemSirolimus



USA. P. TemSirolimus's subsections
Approved in EU & USA
Company
Mechanism: mTOR KInase Inhibition
Patent>Assignee; Claims; No.; Etc.
TradeMark
TradeMark Web-Site
UpDate: 2007. 11.26

USA. P. TemSirolimus's products
This section has no products